Before we pick a stock, we picture the world in five to ten years. Here are the seven futures we're watching, how big each market could get according to published research, and which of our holdings help build them.
Every market-size figure links to the public research it comes from. Where no credible figure exists, we say so.
Robotaxis are being priced as cheaper Ubers. We think that misses most of the opportunity: a car with no driver becomes a 24/7 asset that can serve many markets in one day.
First OpenClaw went viral, then Hermes, Grok Bot and Meta's Muse. Soon everyone has an agent. The question is how you'll talk to it. Our bet: voice.
Cheap, reusable rockets turn orbit into infrastructure: broadband everywhere, sensing, defense and more.
AI that out-thinks the best humans in most fields, and the factories of chips and power needed to build it.
AI with a body: humanoid robots and smarter machines in factories, warehouses and eventually homes.
AI that runs where you are: in your car, glasses, PC, phone, robot or factory floor, not only in the cloud.
AI-accelerated biology, breakthrough drug classes and personalized care that add healthy years.
Not investment advice. Market forecasts are third-party estimates and may prove wrong. The EarlyConviction team holds positions in every ticker shown. Disclaimer.
The same holdings, grouped by the part of the stack they build.
Every industry is being rebuilt on accelerated computing. Data centers are turning into AI factories that convert power and data into intelligence, and the chips and memory inside them are the scarcest ingredients.
AI's real constraint is increasingly electricity and buildable sites. Grid connections can take years, so capacity that already has power attached — or can generate its own — becomes strategic.
AI moves from chatbots to agents that do real work inside companies and consumer apps. The winners own the data, the workflows and the distribution where that work happens.
AI leaves the screen and enters the physical world: cars that drive themselves, humanoid robots in factories and homes, and cheap access to orbit powering global connectivity.
Software-first companies are rebuilding finance and healthcare around the customer, using AI to personalize products and run leaner than incumbents.
Not every conviction is an AI name. We hold one high-risk, high-potential biotech position where a single therapy could address a large, underserved market.